glp-1 drugs and anesthesia Are Serious Risks of Semaglutide Other Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia ASA Advises No Longer Holding

Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice

Prevent the serious risks of vitamin D deficiency, such as bone disorders and increased infection susceptibility

Participants received the drug for 12 months and/or continued to take their standard of care medication, such as l-DOPA

GHK-Cu Key Findings Behavioral Improvements Treatment with intranasal GHK-Cu significantly enhanced performance in the Y-Maze test

Most of the aberrant miRNA levels can alter the secretion of inflammatory cytokines or MMPs, further affecting the procession of RA